Masashi Shimoda

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Masashi Shimoda, Yukiko Kanda, Sumiko Hamamoto et al. · Diabetologia · 2011 · 157 citations · Full text

Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study

Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima et al. · Journal of Diabetes Investigation · 2020 · 95 citations · Full text

Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients

Naofumi Oda, Kenzo Shimazu, Yasuto Naoi et al. · Breast Cancer Research and Treatment · 2012 · 83 citations

Independent Predictive Factor, Breast Oncology, Cancer Immunosurveillance +12

Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist

Yukiko Kanda, Masashi Shimoda, Sumiko Hamamoto et al. · American Journal of Physiology-Endocrinology and Metabolism · 2009 · 63 citations · Full text

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice

Seizo Okauchi, Masashi Shimoda, Atsushi Obata et al. · Biochemical and Biophysical Research Communications · 2015 · 62 citations

Obesity, Metabolic Syndrome, Diabetes Management +11